MedTrace Logo

WAVE Study- Walking and Aging in VErona Study

NCT03212391 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2017-07-11

No results posted yet for this study

Summary

Monocentric unblinded two parallel-group randomized controlled trial to evaluate the effect of diet with or without Nordic Walking on weight loss, physical performance and cardiovascular risk factors in overweight and obese population

Conditions

  • Abdominal Obesity
  • Metabolic Syndrome
  • Disability Physical
  • Sarcopenic Obesity
  • Hypertension
  • Overweight and Obesity
  • Cardiovascular Risk Factor

Interventions

BEHAVIORAL

Diet

52 weeks of Diet supervised by a dietician

BEHAVIORAL

Walking

26 weeks supervised Walking 3 times per week, followed by 26 weeks of unsupervised Walking

BEHAVIORAL

Nordic Walking

26 weeks supervised Nordic Walking 3 times per week, followed by 26 weeks of unsupervised Nordic Walking

Sponsors & Collaborators

  • Universita di Verona

    collaborator OTHER

  • Azienda Ospedaliera Universitaria Integrata Verona

    lead OTHER

Principal Investigators

  • Mauro Zamboni · AOUI Verona

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-19
Primary Completion
2018-01-20
Completion
2018-07-20

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03212391 on ClinicalTrials.gov